Legal & General Group’s BioVie BIVI Stock Holding History

Legal & General Group’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4	Closed	-$224	–	3426
2024 Q1	$224	Hold	4	–	–	﹤0.01%	3359
2023 Q4	$534	Hold	4	–	–	﹤0.01%	3376
2023 Q3	$1.45K	Hold	4	–	–	﹤0.01%	3408
2023 Q2	$1.83K	Buy	+4	New	+$2.69K	﹤0.01%	3401

Other funds holding BIVI

ACM

Altium Capital Management New York $42M AUM

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Legal & General Group's BIVI Position: Q2 2024 in Review

Legal & General Group sold out of BioVie (BIVI) in Q2 2024, closing a stake of 4 shares — an estimated $224 sold.

Legal & General Group first reported a position in BIVI in Q2 2023 and held it in 4 quarters. The position peaked at $1.83K in Q2 2023. 48 funds tracked by Wall St. Rank hold BIVI as of Q2 2024.

Legal & General Group reported no remaining BioVie position as of Q2 2024 after selling out during the quarter.
Legal & General Group sold 4 BioVie shares in Q2 2024, an estimated $224.
Legal & General Group first reported a position in BioVie in Q2 2023 and held it in 4 quarters.
Legal & General Group's BioVie position peaked at $1.83K in Q2 2023.
48 funds tracked by Wall St. Rank held BioVie as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.